The Government may impose an anti-dumping duty of up to $9.03 per kg on a raw material that is imported from a few European countries and is used in the manufacture of drugs to protect domestic players.
In its findings, the Directorate-General of Anti-Dumping and Allied Duties (DGAD) has recommended imposition of the duty on imports of ‘bulk drug Cefadroxil Monohydrate’ from the European Union, the Commerce Ministry said in a notification.
Bulk drug Cefadroxil Monohydrate is an active pharmaceutical ingredient (a raw material) used for the manufacture of pharmaceutical formulations. This bulk drug is used to manufacture formulations that are consumed by patients on the prescription of doctors.
The Directorate’s recommendation comes on the basis of its findings that increased imports have caused “material injury” to the domestic industry, it said.
The DGAD, which is under the Commerce Ministry, in its recommendations said the chemical has been exported to India below its normal value from the European Union.
“...the Authority is of the view that imposition of definitive anti-dumping duty is required to offset dumping and consequent injury...the Authority recommends imposition of definitive anti-dumping...so as to remove injury to the domestic industry,” it added.
Anti-dumping duty is recommended by the Commerce Ministry, while the Finance Ministry imposes the same.
“It is noted that imports from the EU have recorded a significant increase in absolute terms during the injury period from 124.19 tonnes in 2007-08 to 287.25 tonnes during the period of investigation (April 2010 to September 2011),” it said.
Unlike safeguard duties, which are levied in a uniform way, anti-dumping duties vary from product to product and from country to country.
Countries initiate anti-dumping probes to check if domestic industry has been hurt because of a surge in below-cost imports. As a counter-measure, they impose duties under the multilateral WTO regime.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.